Peking University BIOPIC Scientists Raise Concerns about SARS.CoV.2 Mutant JN.1

A team of scientific collaborators led by scientists at the Biomedical Pioneering Innovation Center (BIOPIC), Peking University in Beijing, People’s Republic China report on the potentially troubling JN.1 strain of SARS-CoV-2, the variant behind COVID-19.

The SARS-CoV-2 saltation variant BA.2.86, which was quickly designated as a variant under monitoring after its emergence, attracted global attention. While BA.2.86 hasn’t demonstrated significant  humoral immune escape and growth advantage compared with current dominant variants such as EG.5.1 and HK.3, the pathogen evidence notably high ACE2 binding affinity.